Pregled bibliografske jedinice broj: 1076954
Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report
Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report // Cardiol Croat. 2018 ; 13(1-2):36
Zagreb: Medical Publishing, d.o.o., 2018. str. 36-36 doi:10.15836/ccar2018.36 (poster, recenziran, prošireni sažetak, znanstveni)
CROSBI ID: 1076954 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Rosuvastatin-induced rhabdomyolysis – the
possible role of ticagrelor and the patient’s
pharmacogenetic profile: a case report
Autori
Ladić, Iva ; Vrkić Kirhmajer, Majda ; Putarek, Krešimir ; Banfić, Ljiljana ; Božina, Nada
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, znanstveni
Izvornik
Cardiol Croat. 2018 ; 13(1-2):36
/ - Zagreb : Medical Publishing, d.o.o., 2018, 36-36
Skup
CroIntervent
Mjesto i datum
Zagreb, Hrvatska, 8 - 10. 3. 2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Recenziran
Ključne riječi
rhabdomyolysis, rosuvastatin, ticagrelor
Sažetak
Dual antiplatelet therapy and statins are the cornerstone of acute coronary syndrome (ACS) treatment. Interaction between these drugs can be affected by differences in inter- individual pharmacokinetics/pharmacogenetics. Rhabdomyolysis is adverse reaction of statins. Previous reports suggested that concomitant use of ticagrelor may add an additional risk in developing statin induced rhabdomyolysis. We present a case of rosuvastatin and ticagrelor induced rhabdomyolysis
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Krešimir Putarek
(autor)
Nada Božina
(autor)
Majda Vrkić Kirhmajer
(autor)
Ljiljana Banfić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
